Explore Business Standard
Don’t miss the latest developments in business and finance.
Book Building - SME
₹ 29.75
₹ 101
1200
₹ 1,21,200.00
NSE - SME
15-May-2025
17-May-2025
22-May-2025
Initial public offer of upto 29,46,000 equity shares of face value of Rs. 10/- each (the equity shares) of Accretion Pharmaceuticals Limited (the company or accretion or the issuer) at an issue price of Rs. 101 per equity share for cash, aggregating up to Rs. 29.75 crores (public issue) out of which 1,47,600 equity shares of face value of Rs. 10 each, at an issue price of Rs. 101 per equity share for cash, aggregating Rs. 1.49 crores will be reserved for subscription by the market maker to the issue (the market maker reservation portion). The public issue less market maker reservation portion i.e., issue of 27,98,400 equity shares of face value of Rs. 10 each, at an issue price of Rs. 101 per equity share for cash, aggregating upto Rs. 28.26 crores is herein after referred to as the net issue. The public issue and net issue will constitute 26.50% and 25.17% respectively of the post-issue paid-up equity share capital of our company. <br /><br /><br />
Capital expenditure towards purchase of new equipment/machineries, etc. Capital expenditure towards upgradation of existing mfg facility. Expenditure in connection with product registration in overseas market. Repayment/prepayment of certain borrowings availed by the company. Funding working capital requiremnts. General corporate purposes.
Accretion Pharmaceuticals Ltd, Karvy Selenium Tow-B, 31&32 Financial Dist, Nanakramguda, Hyderabad-500032
Phone - 91-40-67162222
Fax - 91-40-23001153/23420814
Email - care@accretionpharma.com
Website - http:, www.accretionpharma.com